Last update 01 Nov 2024

CTNNB x CLEC-2

Basic Info

Related Targets
CTNNBCLEC-2

Related

1
Drugs associated with CTNNB x CLEC-2
Fucoidan
Target
CLEC-2 x CTNNB
Mechanism
CLEC-2 agonists [+1]
Active Org.
Taipei Medical UniversityTaipei Medical University [+2]
Originator Org.
Jiangsu Provincial People's Hospital
Active Indication
Helicobacter pylori infection [+3]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
30
Clinical Trials associated with CTNNB x CLEC-2
CTRI/2024/07/071419 / Not yet recruitingPhase 4
A randomized, double-blind, placebo-controlled study to assess the effect of fucoidan on prostate health in males with benign prostatic hyperplasia - NIL
RPCEC00000443 / SuspendedPhase 1IIT
Effect of the prebiotic OCEAN ACTIVES® Fucoidan in promoting a healthy intestinal microbiome
ChiCTR2400081499 / SuspendedPhase 4IIT
Clinical effect and mechanism of fucoidan on Helicobacter pylori eradication
100 Clinical Results associated with CTNNB x CLEC-2
Login to view more data
100 Translational Medicine associated with CTNNB x CLEC-2
Login to view more data
0 Patents (Medical) associated with CTNNB x CLEC-2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free